The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Contralateral breast cancer risk in patients with familial breast cancer who tested negative for BRCA1 and BRCA2.
K. Rhiem
No relevant relationships to disclose
C. Engel
No relevant relationships to disclose
M. Graeser
No relevant relationships to disclose
W. Janni
No relevant relationships to disclose
M. Kiechle
No relevant relationships to disclose
N. Ditsch
No relevant relationships to disclose
C. Mundhenke
No relevant relationships to disclose
R. Kreienberg
No relevant relationships to disclose
J. Tio
No relevant relationships to disclose
M. Golatta
No relevant relationships to disclose
A. Honig
No relevant relationships to disclose
D. Gadzicki
No relevant relationships to disclose
D. Speiser
No relevant relationships to disclose
K. Kast
No relevant relationships to disclose
S. Briest
No relevant relationships to disclose
A. Meindl
No relevant relationships to disclose
R. Schmutzler
No relevant relationships to disclose